Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current and prospective computational approaches and challenges for developing COVID-19 vaccines
Woochang Hwang, Winnie Lei, Nicholas M. Katritsis, et al.
Advanced Drug Delivery Reviews (2021) Vol. 172, pp. 249-274
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Artificial Intelligence-Based Data-Driven Strategy to Accelerate Research, Development, and Clinical Trials of COVID Vaccine
Ashwani Sharma, Tarun Virmani, Vipluv Pathak, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 82
Jet injectors: Perspectives for small volume delivery with lasers
Jelle J. Schoppink, David Fernández Rivas
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114109-114109
Open Access | Times Cited: 67
Allele Frequency Net Database
Faviel F. González-Galarza, Antony McCabe, Eduardo José Melo dos Santos, et al.
Methods in molecular biology (2024), pp. 19-36
Closed Access | Times Cited: 9
Resources and computational strategies to advance small molecule SARS-CoV-2 discovery: Lessons from the pandemic and preparing for future health crises
Natesh Singh, Bruno O. Villoutreix
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 2537-2548
Open Access | Times Cited: 28
COVID-19 vaccines development in Africa: a review of current situation and existing challenges of vaccine production
Emmanuel Lamptey, Ephraim Kumi Senkyire, Dooshima Aki Benita, et al.
Clinical and Experimental Vaccine Research (2022) Vol. 11, Iss. 1, pp. 82-82
Open Access | Times Cited: 22
Anti-COVID-19 Nanomaterials: Directions to Improve Prevention, Diagnosis, and Treatment
Mohammad Souri, Mohsen Chiani, Ali Akbar Farhangi, et al.
Nanomaterials (2022) Vol. 12, Iss. 5, pp. 783-783
Open Access | Times Cited: 22
COVID-19 Vaccines: Computational tools and Development
Victor Chukwudi Osamor, Excellent Ikeakanam, Janet Bishung, et al.
Informatics in Medicine Unlocked (2023) Vol. 37, pp. 101164-101164
Open Access | Times Cited: 13
Computational Approaches in the Discovery and Development of Therapeutic and Prophylactic Agents for Viral Diseases
Anand Gaurav, Neetu Agrawal, Mayasah Al‐Nema, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 26, pp. 2190-2206
Closed Access | Times Cited: 18
Bioinformatics analysis of the in silico engineered protein vaccine with and without Escherichia coli heat labile enterotoxin adjuvant on the model of Klebsiella pneumoniae
Kimia Jafari Ranjbar, Parisa Sarkoohi, Behzad Shahbazi, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Computational tools and data integration to accelerate vaccine development: challenges, opportunities, and future directions
Lindsey Anderson, Charles Tapley Hoyt, Jeremy Zucker, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Application of in-silico approaches in subunit vaccines: Overcoming the challenges of antigen and adjuvant development
Xue Tang, Jiayin Deng, Chun‐Ting He, et al.
Journal of Controlled Release (2025), pp. 113629-113629
Closed Access
A new paradigm for drug discovery in the treatment of complex diseases: drug discovery and optimization
Yu Yuan, Lu-Lu Yu, Chenghao Bi, et al.
Chinese Medicine (2025) Vol. 20, Iss. 1
Open Access
Rational in-silico design of a multi-epitope vaccine against human Rhinovirus an immune simulation and molecular dynamics simulation approach
Najeebullah, Inamul Haq, Muhammad Rahiyab, et al.
Vacunas (2025), pp. 500427-500427
Closed Access
The Advantage of Using Immunoinformatic Tools on Vaccine Design and Development for Coronavirus
Jazmín García‐Machorro, G. Lizbeth Ramírez-Salinas, Marlet Martínez‐Archundia, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1844-1844
Open Access | Times Cited: 15
Lymphatic distribution considerations for subunit vaccine design and development
Paul R. Hartmeier, Sarah M. Ostrowski, Emelia E. Busch, et al.
Vaccine (2024) Vol. 42, Iss. 10, pp. 2519-2529
Closed Access | Times Cited: 3
Immune landscape and redox imbalance during neurological disorders in COVID-19
Abhimanyu Thakur, Vartika Sharma, Sera Averbek, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 9
Open Access | Times Cited: 7
Immunoinformatics for Novel Multi-Epitope Vaccine Development in Canine Parvovirus Infections
Bashudeb Paul, Jahangir Alam, Mridha Md. Kamal Hossain, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2180-2180
Open Access | Times Cited: 6
Development of multivalent vaccine targeting M segment of Crimean Congo Hemorrhagic Fever Virus (CCHFV) using immunoinformatic approaches
Maaza Sana, Aneela Javed, Syed Babar Jamal, et al.
Saudi Journal of Biological Sciences (2021) Vol. 29, Iss. 4, pp. 2372-2388
Open Access | Times Cited: 14
Identifying COVID-19 optimal vaccine dose using mathematical immunostimulation/immunodynamic modelling
Sophie Rhodes, Neal P. Smith, Thomas G. Evans, et al.
Vaccine (2022) Vol. 40, Iss. 49, pp. 7032-7041
Open Access | Times Cited: 8
Computational Approaches to Designing Antiviral Drugs against COVID-19: A Comprehensive Review
Mohan Singh, Nidhi Singh, Divya Mishra, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 33, pp. 2601-2617
Closed Access | Times Cited: 3
Computational Approach to Combat COVID-19 Infection: Emerging Tools for Accelerating Drug Research
Biswa Mohan Sahoo, Subrat Kumar Bhattamisra, Sarita Das, et al.
Current Drug Discovery Technologies (2022) Vol. 19, Iss. 3
Closed Access | Times Cited: 5
Probing the Immune System Dynamics of the COVID-19 Disease for Vaccine Designing and Drug Repurposing Using Bioinformatics Tools
Deepshikha Yadav, Shriya Agarwal, Pranav Pancham, et al.
Immuno (2022) Vol. 2, Iss. 2, pp. 344-371
Open Access | Times Cited: 4
COVID-19 vaccination: Is it a matter of concern?
Poonam Kushwaha, Ashish Pundhir, Anju Gahlot
Journal of Family Medicine and Primary Care (2022) Vol. 11, Iss. 6, pp. 2431-2436
Open Access | Times Cited: 4
The race to understand immunopathology in COVID-19: Perspectives on the impact of quantitative approaches to understand within-host interactions
Sonia Gazeau, Xiaoyan Deng, Hsu Kiang Ooi, et al.
ImmunoInformatics (2023) Vol. 9, pp. 100021-100021
Open Access | Times Cited: 2
Epitope-based vaccine design against the membrane and nucleocapsid proteins of SARS-CoV-2
Mona Moballegh Naseri, Mohammad Moballegh Naseri, Vineet Kumar Maurya, et al.
Dental and Medical Problems (2023) Vol. 60, Iss. 3, pp. 489-495
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top